Your browser doesn't support javascript.
loading
Referring Hospitalized Smokers to Outpatient Quit Services: A Randomized Trial.
Fellows, Jeffrey L; Mularski, Richard A; Leo, Michael C; Bentz, Charles J; Waiwaiole, Lisa A; Francisco, Melanie C; Funkhouser, Kimberly; Stoney, Catherine M.
Afiliación
  • Fellows JL; Kaiser Permanente Center for Health Research, Portland, Oregon. Electronic address: jeffrey.fellows@kpchr.org.
  • Mularski RA; Kaiser Permanente Center for Health Research, Portland, Oregon.
  • Leo MC; Kaiser Permanente Center for Health Research, Portland, Oregon.
  • Bentz CJ; Tobacco Cessation and Prevention, Legacy Health System, Portland, Oregon;
  • Waiwaiole LA; Kaiser Permanente Center for Health Research, Portland, Oregon.
  • Francisco MC; Kaiser Permanente Center for Health Research, Portland, Oregon.
  • Funkhouser K; Kaiser Permanente Center for Health Research, Portland, Oregon.
  • Stoney CM; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.
Am J Prev Med ; 51(4): 609-19, 2016 10.
Article en En | MEDLINE | ID: mdl-27647061
INTRODUCTION: Linking outpatient cessation services to bedside counseling for hospitalized smokers can improve long-run quit rates. Adding an assisted referral (AR) offer to a tobacco treatment specialist consult service fits the team approach to care in U.S. hospitals. DESIGN: A two-arm patient-randomized trial tested the effectiveness of adding an AR offer to outpatient smoking-cessation services and interactive voice recognition (AR+IVR) follow-up to a usual care (UC) tobacco-cessation consult for hospitalized smokers. SETTING/PARTICIPANTS: Over 24 months (November 2011-November 2013), 898 hospitalized adult smokers interested in quitting smoking were recruited from three large hospitals in the Portland, Oregon, area: an integrated group model HMO (n=622), a community hospital (n=195), and an academic health center (n=81). INTERVENTION: Tobacco treatment specialists identified smokers and provided an intensive bedside tobacco use assessment and cessation consultation (UC). AR+IVR recipients also received proactive ARs to available outpatient counseling programs and medications, and linked patients to a tailored IVR telephone follow-up system. MAIN OUTCOME MEASURES: The primary outcome was self-reported 30-day abstinence at 6-month follow-up. Secondary outcomes included self-reported and continuous abstinence and biochemically confirmed 7-day abstinence at 6 months. Follow-up was completed in September 2014; data were analyzed in 2015. RESULTS: A total of 597 and 301 hospitalized smokers were randomized to AR+IVR and UC, respectively. AR+IVR and UC recipients received 19.3 and 17.0 minutes of bedside counseling (p=0.372), respectively. Most (58%) AR+IVR patients accepted referrals for counseling, 43% accepted medications, and 28% accepted both. Self-reported 30-day abstinence for AR+IVR (17.9%) and UC (17.3%) were not statistically significant (p=0.569). Differences in 7-day, continuous, and biochemically confirmed abstinence by treatment group also were insignificant, overall and adjusting for site. CONCLUSIONS: Adding an AR to outpatient counseling and medications did not increase cigarette abstinence at 6 months compared to UC alone.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Derivación y Consulta / Cese del Hábito de Fumar Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Am J Prev Med Asunto de la revista: SAUDE PUBLICA Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Derivación y Consulta / Cese del Hábito de Fumar Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Am J Prev Med Asunto de la revista: SAUDE PUBLICA Año: 2016 Tipo del documento: Article